EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment beyond progression in the Herceptin pivotal combination chemotherapy trial



Treatment beyond progression in the Herceptin pivotal combination chemotherapy trial



Breast Cancer Research & Treatment 64(1): 32, November




(PDF 0-2 workdays service: $29.90)

Accession: 035980080

Download citation: RISBibTeXText



Related references

Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trials. Oncology 61 Suppl 2: 14-21, 2001

Effect of cardiac dysfunction on treatment outcome in the Herceptin pivotal trial. Breast Cancer Research & Treatment 69(3): 303, October, 2001

Association of topoisomerase II-alpha (TOP2A) gene amplification with responsiveness to anthracycline-containing chemotherapy among women with metastatic breast cancer entered in the Herceptin H0648g pivotal clinical trial. Journal of Clinical Oncology 23(16_suppl): 9543-9543, 2016

The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surgery for Obesity and Related Diseases 11(4): 874-881, 2016

Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: pivotal trial data. Annals of Oncology 12 Suppl 1: S57-S62, 2001

Phase II trial of Herceptin induction followed by combination therapy with paclitaxel and carboplatin A Minnie Pearl Research Network trial. Breast Cancer Research & Treatment 64(1): 31, November, 2000

Herceptin improves time to progression following chemotherapy in women with metastatic breast cancer. European Journal of Cancer 35(SUPPL 4): S314, Sept, 1999

Safety profile of Herceptin as a single agent and in combination with chemotherapy. European Journal of Cancer 35(SUPPL 4): S324, Sept, 1999

Herceptin and chemotherapy combination active in advanced breast cancer. Cancer Biology & Therapy 3(6): 489-489, 2005

Combination therapy for advanced pancreatic cancer using Herceptin plus chemotherapy. International Journal of Oncology 27(4): 1125-1130, 2005

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study. Annals of Oncology 25(7): 1340-1346, 2015

Combination therapy herceptin+taxotere/Herceptin+navelbine. Onkologie 25 Suppl 5: 15-16, 2013

Therapeutic advantage of chemotherapy drugs in combination with Herceptin against human breast cancer cells with HER-2/neu overexpression. Breast Cancer Research & Treatment 57(1): 114, 1999